MedTrace Logo

The Effect of Prebiotic B-GOS on the Immune Function, Metabolism and Gut Microbiota of Elderly People

NCT01303484 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-03-25

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of prebiotic B-GOS on the immune function, metabolism and gut microbiota of elderly people

Conditions

  • Immunosenescence

Interventions

DIETARY_SUPPLEMENT

Bi2muno® GOS

5.5g/day for 10 weeks

DIETARY_SUPPLEMENT

Maltodextrin

5.5g daily for 10 weeks

Sponsors & Collaborators

  • University of Reading

    collaborator OTHER

  • Clasado

    lead INDUSTRY

Principal Investigators

  • Glenn Gibson, PhD · University of Reading, United Kingdom

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-11-30
Completion
2014-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01303484 on ClinicalTrials.gov